Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $7.33 up 2.09% from its previous closing price of $7.18. In other words, the price has increased by $2.09 from its previous closing price. On the day, 0.89 million shares were traded. DNA stock price reached its highest trading level at $7.45 during the session, while it also had its lowest trading level at $7.03.
Ratios:
For a deeper understanding of Ginkgo Bioworks Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.71 and its Current Ratio is at 4.71. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.54.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 11 ’24 when Che Austin bought 99 shares for $7.08 per share.
Che Austin bought 99 shares of DNA for $773 on Oct 10 ’24. On Oct 09 ’24, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $8.27 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 407367680 and an Enterprise Value of 102826552. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.09 while its Price-to-Book (P/B) ratio in mrq is 0.43. Its current Enterprise Value per Revenue stands at 0.558 whereas that against EBITDA is -0.162.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $75.20, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is -10.27%, while the 200-Day Moving Average is calculated to be -75.40%.
Shares Statistics:
For the past three months, DNA has traded an average of 1.49M shares per day and 846310 over the past ten days. A total of 38.13M shares are outstanding, with a floating share count of 35.44M. Insiders hold about 32.59% of the company’s shares, while institutions hold 43.41% stake in the company. Shares short for DNA as of 1727654400 were 8187416 with a Short Ratio of 5.49, compared to 1724976000 on 7148536. Therefore, it implies a Short% of Shares Outstanding of 8187416 and a Short% of Float of 26.25.
